Backed by 5AM Ventures.
About the role
We are a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies. Our mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases. We aim to develop therapies that patients and physicians can utilize in a community setting. Our lead product candidate, AlloNK® , is a non-genetically modified, cryopreserved NK cell therapy being evaluated in combination with B-cell targeted monoclonal antibodies (mAbs).
More about this role
We are a clinical-stage biotechnology company focused on developing natural killer (NK) cell-based therapies. Our mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases. We aim to develop therapies that patients and physicians can utilize in a community setting. Our lead product candidate, AlloNK® , is a non-genetically modified, cryopreserved NK cell therapy being evaluated in combination with B-cell targeted monoclonal antibodies (mAbs). We believe the compelling cell killing properties of NK cells, when combined with mAbs for targeting, create an opportunity to generate potentially transformative therapies.
Lead. Validate. Transform Cell Therapies.
Drive the manufacturing future of allogeneic NK cell therapy.
Artiva is seeking a Director, MSAT, CMC & Process Validation to lead end-to-end process validation as we advance toward Phase 3. Own the journey from process characterization through PPQ and continued process verification , partnering across MSAT, CMC, Quality, and GMP Manufacturing. Late-stage development experience and hands-on PPQ execution are must-haves. Join a nimble biotech. Lead critical work. Make a...
Browse similar: Startup jobs